The Health Ministry in Israel has announced a new plan to simplify and speed up the process for approving new medications. The plan aims to shorten the time of registering new medications, making drugs more readily available to the public while maintaining high safety standards. It will include expedited registration tracks for drugs already approved by leading authorities and will provide regulatory flexibility for rare diseases and emergency use cases. The plan is set to begin in March 2025 and is based on advanced Western regulatory standards.